BeOne Medicines (ONC) Deferred Taxes (2017 - 2023)
BeOne Medicines (ONC) reported Deferred Taxes of -$46000.0 for Q4 2023, down 102.74% year-over-year from $1.7 million in Q4 2022, and down 106.13% on a QoQ basis from $750000.0 in Q3 2023.
BeOne Medicines (ONC) has 7 years of Deferred Taxes data on file, last reported at -$46000.0 in Q4 2023.
- Quarterly Deferred Taxes fell 102.74% year-over-year to -$46000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $689000.0 (down 66.54% YoY) and the FY2025 annual result came in at $9.5 million, down 63.56% from the prior year.
- Deferred Taxes eased to -$46000.0 in Q4 2023 per ONC's latest filing, from $750000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $14.8 million in Q3 2021 and bottomed at -$12.3 million in Q1 2021.
- The 5-year median for Deferred Taxes is -$48500.0 (2023), against an average of -$142300.0.
- The widest annual swing landed in 2021, when Deferred Taxes tumbled 5847.09%; it then surged 941.67% in 2022.
- Tracing ONC's Deferred Taxes over 5 years: stood at $4.1 million in 2019, then soared by 119.97% to $9.0 million in 2020, then plunged by 89.99% to $903000.0 in 2021, then soared by 85.94% to $1.7 million in 2022, then plunged by 102.74% to -$46000.0 in 2023.
- Per Business Quant, the three latest ONC Deferred Taxes figures stand at -$46000.0 (Q4 2023), $750000.0 (Q3 2023), and -$51000.0 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 96.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 9.31 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -46,000.00 |
| Sep 30, 2023 | 750,000.00 |
| Jun 30, 2023 | -51,000.00 |
| Mar 31, 2023 | 36,000.00 |
| Dec 31, 2022 | 1.68 Mn |
| Sep 30, 2022 | -175,000.00 |
| Jun 30, 2022 | 505,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 903,000.00 |
| Sep 30, 2021 | 14.79 Mn |
| Jun 30, 2021 | -60,000.00 |
| Mar 31, 2021 | -12.25 Mn |
| Dec 31, 2020 | 9.02 Mn |
| Sep 30, 2020 | -7.70 Mn |
| Jun 30, 2020 | -854,000.00 |
| Mar 31, 2020 | -206,000.00 |
| Dec 31, 2019 | 4.10 Mn |
| Sep 30, 2019 | -11.88 Mn |
| Jun 30, 2019 | -473,000.00 |
| Mar 31, 2019 | -983,000.00 |
| Dec 31, 2018 | -13.15 Mn |
| Sep 30, 2018 | -385,000.00 |
| Jun 30, 2018 | -4.32 Mn |
| Mar 31, 2018 | -4.09 Mn |
| Dec 31, 2017 | 26,000.00 |
| Sep 30, 2017 | -1.81 Mn |
| Jun 30, 2017 | -1.90 Mn |
| Mar 31, 2017 | -2.16 Mn |